5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION
申请人:Lophora ApS
公开号:US20210137908A1
公开(公告)日:2021-05-13
The present invention relates to agonists of the 5-HT
2A
serotonin receptors and their medical uses. In one aspect the invention relates to 5-HT
2A
agonists of formula (I). In second aspect, the invention relates to selective 5-HT
2A
agonists of formula (II). In another aspect, the invention relates to mixed 5-HT
2A
/5-HT
2C
agonists of formula (III). In yet another aspect, the invention relates to 5-HT
2A
agonists for use in the treatment of a depressive disorder, more particular a 5-HT
2A
agonist for the use in the treatment of treatment-resistant depression.
The dihalopropene compounds of the general formula \x9bI! have excellent insecticidal/acaricidal activity, so that they are satisfactorily effective for the control of noxious insects, mites and ticks.
5-HT2A agonists for use in treatment of depression
申请人:Lophora ApS
公开号:US11246860B2
公开(公告)日:2022-02-15
The present invention relates to agonists of the 5-HT2A serotonin receptors and their medical uses. In one aspect the invention relates to 5-HT2A agonists of formula (I). In second aspect, the invention relates to selective 5-HT2A agonists of formula (II). In another aspect, the invention relates to mixed 5-HT2A/5-HT2C agonists of formula (III). In yet another aspect, the invention relates to 5-HT2A agonists for use in the treatment of a depressive disorder, more particular a 5-HT2A agonist for the use in the treatment of treatment-resistant depression.